The polycrystalline Compound C inhibitor samples of GaxCo4Sb12 (x = 0.05, 0.10, 0.15, 0.20, 0.25, and 0.30) were prepared, and the TE properties were examined from room temperature to 750
K. All the samples were composed of two phases: GaxCo4Sb12 (x = similar to 0.02) as the matrix phase and Ga metal as the second phase. All the samples exhibited negative values of the Seebeck coefficient (S). The Hall carrier concentration slightly increased with increasing x, while the carrier mobility decreased. Although the maximum Ga filling ratio was really low, the kappa was reduced effectively by Ga adding. The maximum value of the dimensionless figure of merit ZT (= (ST)-T-2/rho/kappa, where T is the absolute temperature and rho is the electrical resistivity) was 0.18 at 500 K obtained for Ga0.25Co4Sb12. (C) 2011 American Institute of Physics. [doi:10.1063/1.3606417]“
“In this study, immobilization of laccase (L) enzyme on magnetite (Fe(3)O(4)) nanoparticles was achieved, so that the immobilized enzyme could be used repeatedly. For this purpose, Fe(3)O(4) nanoparticles were coated and
functionalized with chitosan (CS) and laccase from Trametes versicolor was immobilized onto chitosan-coated magnetic nanoparticles (Fe(3)O(4)-CS) by adsorption or covalent binding after activating the hydroxyl groups of chitosan with carbodiimide (EDAC) or cyanuric chloride (CC). For chitosan-coated magnetic nanoparticles, the thickness of CS layer was estimated as 1.0-4.8 nm by TEM, isoelectric point was detected as 6.86 by zeta (zeta)-potential measurements, JQ-EZ-05 and the saturation magnetization was determined as 25.2 emu g(-1) by VSM, indicating that these nanoparticles were almost superparamagnetic. For free laccase and immobilized laccase systems, the optimum pH, temperature, LY2157299 datasheet and kinetic parameters
were investigated; and the change of the activity against repeated use of the immobilized systems were examined. The results indicated that all immobilized systems retained more than 71% of their initial activity at the end of 30 batch uses. (C) 2011 Wiley Periodicals, Inc. J Appl Polym Sci 123:707-716, 2012″
“Etodolac (ET) is a nonsteroidal anti-inflammatory drug with proved potential antitumor and uric acid lowering effects. It shows dissolution rate-dependent bioavailability. This work was carried out to improve the dissolution rate of etodolac using three carriers of known potential to improve solubility and hence dissolution rate of poorly soluble drugs through coevaporation technique. The polymeric surfactant inutec, 2-hydroxypropyl-beta-cyclodextrin, and tromethamine were used at three different drug/carrier ratios. The dissolution rate of ET at pH 1.2 and 6.8 is improved in all of the solid dispersion systems compared to that of the pure drug and physical mixtures. DSC of coevaporates at 1: 5 drug/carrier ratio providing the fastest dissolution rate suggested loss of ET crystallinity which was further confirmed by X-ray diffraction.